The Food and Drug Administration on Wednesday approved Baxter International’s clindamycin injection in saline. Clindamycin is a common antibiotic used to treat serious infections when penicillin may ...
Hikma is offering clindamycin in 5% dextrose injection, in 300mg/50ml, 600mg/50ml and 900mg/50ml doses. The product is available in a vial. Clindamycin in 5% dextrose injection is indicated for the ...
Alvogen Issues Voluntary Nationwide Recall of Clindamycin Injection Due to a Potential for a Lack of
Alvogen is voluntarily recalling seven lots of Clindamycin Injection USP ADD-Vantage Vials to the hospital/retail level due to microbial growth detected during a routine simulation of the ...
Clindamycin (as phosphate) 150mg/mL; contains benzyl alcohol. Serious: 0.6–1.2g daily. More severe: 1.2–2.7g/day IM or IV. Both: give in 2–4 equally divided doses; max 600mg per IM inj and 4.8g/day IV ...
Abraxis BioScience Receives FDA Approvals for Clindamycin Injection, USP LOS ANGELES -- Abraxis BioScience, Inc., an integrated, global biopharmaceutical company, today announced that it has received ...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX), a global leader in sterile medication production and delivery, today announced the U.S. Food and Drug Administration (FDA) ...
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...
The company has voluntarily recalled Clindamycin Injection USP ADD-Vantage Vials to the hospital/retail level because of a lack of sterility assurance. On June 16, 2017, Alvogen announced it was ...
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...
Alvogen is arranging with its distributors and customers for the return of the recalled lots of clindamycin. Hospira, a unit of Pfizer, voluntarily recalled four other injectable solutions made at its ...
DEERFIELD - The U.S. Food and Drug Administration has approved the commercial launch of ready-to-use Baxter International's clindamycin injection in saline in three commonly prescribed formulation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results